• 475 Citations
  • 13 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Area of Expertise

I maintain national certification as a clinical trial investigator through the Association of Clinical Research Professionals and am routinely invited to speak on the scientific, clinical, and technical merits of clinical research.
My research (over 60 clinical trials serving as sole Principal Investigator) has primarily been in the field of antiretrovirals (anti-HIV medicines) but has also included influenza, hepatitis, and numerous other primary care conditions (diabetes, cholesterol, hypertension, and COPD). My research pursuits remain primarily in the conduct of clinical trials involving new and experimental antiviral medications with an emphasis on pharmacokinetic and pharmacodynamic assessments as well as mechanisms by which tolerability or optimization of outcomes can be achieved. Though not always a senior faculty mentor, historically I have always engaged with collaborative and interdisciplinary teams to achieve results beyond that achievable by single perspectives.

Education/Academic qualification

PharmD, University of Oklahoma Health Science Center

BPharm , University of Louisiana at Monroe

Fingerprint Dive into the research topics where Patrick Clay is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
HIV Medicine & Life Sciences
Pharmacists Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Anti-HIV Agents Medicine & Life Sciences
Viral Load Medicine & Life Sciences
Professional Role Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2022

Research Output 1999 2019

Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data

Patient-Centered HIV Care Model Team, 1 Nov 2019, In : Journal of acquired immune deficiency syndromes (1999). 82, 3, p. 245-251 7 p.

Research output: Contribution to journalArticle

Viral Load
Integrase Inhibitors

PaCIR: A tool to enhance pharmacist patient care intervention reporting

Clay, P. G., Burns, A. L., Isetts, B. J., Hirsch, J. D., Kliethermes, M. A. & Planas, L. G., 1 Sep 2019, In : Journal of the American Pharmacists Association. 59, 5, p. 615-623 9 p.

Research output: Contribution to journalArticle

Open Access
Patient Care

Retention in HIV Care among Participants in the Patient-Centered HIV Care Model: A Collaboration between Community-Based Pharmacists and Primary Medical Providers

Byrd, K. K., Hardnett, F., Clay, P. G., Delpino, A., Hazen, R., Shankle, M. D., Camp, N. M., Suzuki, S. & Weidle, P. J., Feb 2019, In : AIDS Patient Care and STDs. 33, 2, p. 58-66 9 p.

Research output: Contribution to journalArticle

Patient-Centered Care
Odds Ratio
Confidence Intervals
4 Citations (Scopus)

A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV

Clay, P. G., Yuet, W. C., Moecklinghoff, C. H., Duchesne, I., Tronczyski, K. L., Shah, S. & Shao, D., 30 Oct 2018, In : AIDS Research and Therapy. 15, 1, 17.

Research output: Contribution to journalArticle

Cost-Benefit Analysis

Are pharmacists’ interventions worthy of publishing?

Clay, P. G., 1 May 2018, In : Journal of the American Pharmacists Association. 58, 3, 1 p.

Research output: Contribution to journalArticle

Hospital Pharmacy Services
Professional Role